Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.64B
| $1.6M | ﹤0.01% |
+36,298
| New | +$1.6M |
|
1877
CALL
Golar LNG
GLNG
$5.31B
| $1.59M | ﹤0.01% |
+32,000
| New | +$1.69M |
|
1878
PUT
Moderna
MRNA
$57.9B
| $1.59M | ﹤0.01% |
+22,700
| New | +$1.17M |
|
1879
CorMedix
CRMD
$639M
| $1.59M | ﹤0.01% |
+202,370
| New | +$1.6M |
|
|
BRSL
1880
Brightstar Lottery PLC
BRSL
$2.21B
| $1.58M | ﹤0.01% |
147,766
-354,902
| -71% | -$4.22M |
|
|
1881
CALL
Moderna
MRNA
$57.9B
| $1.58M | ﹤0.01% |
+22,600
| New | +$1.17M |
|
1882
iShares MSCI Spain ETF
EWP
$2.27B
| $1.58M | ﹤0.01% |
26,640
+22,740
| +583% | +$1.3M |
|
1883
PUT
Trip.com Group
TCOM
$29B
| $1.58M | ﹤0.01% |
39,600
-100
| -0.3% | -$4.96K |
|
1884
Hawaiian Electric Industries
HE
$1.99B
| $1.58M | ﹤0.01% |
+116,476
| New | +$1.66M |
|
1885
Helios Technologies
HLIO
$2.51B
| $1.57M | ﹤0.01% |
+17,621
| New | +$1.35M |
|
1886
Sigma Lithium
SGML
$1.35B
| $1.57M | ﹤0.01% |
124,025
-755,185
| -86% | -$12.7M |
|
1887
First Busey Corp
BUSE
$2.5B
| $1.56M | ﹤0.01% |
52,872
+29,832
| +129% | +$809K |
|
|
AUTL
1888
Autolus Therapeutics
AUTL
$641M
| $1.56M | ﹤0.01% |
972,748
+1,057
| +0.1% | +$1.66K |
|
1889
Iovance Biotherapeutics
IOVA
$3.76B
| $1.55M | ﹤0.01% |
373,284
+124,520
| +50% | +$473K |
|
1890
Euronet Worldwide
EEFT
$2.62B
| $1.55M | ﹤0.01% |
21,197
-97,044
| -82% | -$6.77M |
|
1891
PUT
PNC Financial Services
PNC
$97B
| $1.55M | ﹤0.01% |
+6,300
| New | +$1.41M |
|
1892
CALL
IonQ
IONQ
$18.2B
| $1.55M | ﹤0.01% |
29,100
-83,400
| -74% | -$4.23M |
|
1893
PUT
Kroger
KR
$35.5B
| $1.55M | ﹤0.01% |
27,900
-3,000
| -10% | -$196K |
|
1894
CALL
Teradyne
TER
$58.7B
| $1.55M | ﹤0.01% |
3,200
-6,600
| -67% | -$2.49M |
|
1895
PUT
Monster Beverage
MNST
$93.6B
| $1.55M | ﹤0.01% |
32,200
+19,200
| +148% | +$807K |
|
1896
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $1.55M | ﹤0.01% |
+20,647
| New | +$1.44M |
|
1897
CALL
Riot Platforms
RIOT
$7.44B
| $1.54M | ﹤0.01% |
56,300
-244,700
| -81% | -$5.52M |
|
1898
Monolithic Power Systems
MPWR
$64.7B
| $1.54M | ﹤0.01% |
1,115
+320
| +40% | +$480K |
|
1899
Harmonic Inc
HLIT
$1.36B
| $1.54M | ﹤0.01% |
+94,328
| New | +$1.2M |
|
|
JOYY
1900
JOYY Inc
JOYY
$3.71B
| $1.54M | ﹤0.01% |
23,265
+14,129
| +155% | +$879K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.